Literature DB >> 7820737

Osteonecrosis of the femoral head: current concepts and controversies.

B D Mulliken1.   

Abstract

Despite many investigations into ON of the femoral head, many issues remain unresolved. The pathogenesis in most cases is only speculative and may involve intravascular factors such as microemboli or extravascular factors such as increased interosseous pressure. MRI has emerged as the diagnostic test of choice for suspected early lesions, and radiographs should be used to diagnose and follow advanced lesions. Bone scanning can be useful for early diagnosis and CT scanning or tomography may help plan surgical procedures. The role of the functional exploration of bone is controversial. The natural history of early lesions is unknown; this makes it difficult to evaluate results of treatment. Radiographic ON will usually progress to collapse and arthrosis if treated nonoperatively. The role of core decompression or other joint preserving operations to prevent collapse is controversial, since the reports of success and complication rates have been extremely variable. These procedures are ineffective if used after radiographic collapse. Total hip replacement is the only satisfactory treatment for advanced symptomatic stages, but is relatively contraindicated in young active patients. Further research is needed to assess the natural history of early ON and evaluate the role of surgery in preventing progression.

Entities:  

Mesh:

Year:  1993        PMID: 7820737      PMCID: PMC2328992     

Source DB:  PubMed          Journal:  Iowa Orthop J        ISSN: 1541-5457


  1 in total

1.  Radial head-capitellum view in elbow trauma.

Authors:  R W Head
Journal:  AJR Am J Roentgenol       Date:  1983-06       Impact factor: 3.959

  1 in total
  1 in total

1.  Long-term followup of vascularized fibular grafting for femoral head necrosis.

Authors:  Myung-Chul Yoo; Kang-Il Kim; Chung-Soo Hahn; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2008-03-11       Impact factor: 4.176

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.